Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuelle Charpentier

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Nature Chemical Biology|March 4, 2020
Bridge helix arginines play a critical role in Cas9 sensitivity to mismatchesMajda Bratovič, Ines Fonfara, Krzysztof Chylinski, et al.
Investigational New Drugs|November 19, 2014
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agentFarid Ouchani, Albin Jeanne, Jessica Thevenard, et al.
Molecular Cell|July 2, 2019
Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial VirulenceHannah K Ratner, Andrés Escalera-Maurer, Anaïs Le Rhun, et al.
Molecular Microbiology|September 25, 2004
Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA moleculeMonika Mangold, Maria Siller, Bernhard Roppenser, et al.
Mbio|November 3, 2016
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A StreptococcusUlrike Resch, James Anthony Tsatsaronis, Anaïs Le Rhun, et al.
Msystems|March 28, 2024
<i>Bacillus subtilis</i> remains translationally active after CRISPRi-mediated replication initiation arrestVanessa Muñoz-Gutierrez, Fabián A Cornejo, Katja Schmidt, et al.
Nature Communications|June 29, 2021
Control of membrane barrier during bacterial type-III protein secretionSvenja Hüsing, Manuel Halte, Ulf van Look, et al.
Biomaterials|May 11, 2016
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytesVerena Labenski, Julia D Suerth, Elke Barczak, et al.
The Journal of Biological Chemistry|May 16, 2008
Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9Nina Gratz, Maria Siller, Barbara Schaljo, et al.
Cell Host & Microbe|October 28, 2020
Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella sppEric J C Gálvez, Aida Iljazovic, Lena Amend, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Nature Chemical Biology|March 4, 2020
Bridge helix arginines play a critical role in Cas9 sensitivity to mismatchesMajda Bratovič, Ines Fonfara, Krzysztof Chylinski, et al.
Investigational New Drugs|November 19, 2014
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agentFarid Ouchani, Albin Jeanne, Jessica Thevenard, et al.
Molecular Cell|July 2, 2019
Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial VirulenceHannah K Ratner, Andrés Escalera-Maurer, Anaïs Le Rhun, et al.
Molecular Microbiology|September 25, 2004
Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA moleculeMonika Mangold, Maria Siller, Bernhard Roppenser, et al.
Mbio|November 3, 2016
A Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A StreptococcusUlrike Resch, James Anthony Tsatsaronis, Anaïs Le Rhun, et al.
Msystems|March 28, 2024
<i>Bacillus subtilis</i> remains translationally active after CRISPRi-mediated replication initiation arrestVanessa Muñoz-Gutierrez, Fabián A Cornejo, Katja Schmidt, et al.
Nature Communications|June 29, 2021
Control of membrane barrier during bacterial type-III protein secretionSvenja Hüsing, Manuel Halte, Ulf van Look, et al.
Biomaterials|May 11, 2016
Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytesVerena Labenski, Julia D Suerth, Elke Barczak, et al.
The Journal of Biological Chemistry|May 16, 2008
Group A streptococcus activates type I interferon production and MyD88-dependent signaling without involvement of TLR2, TLR4, and TLR9Nina Gratz, Maria Siller, Barbara Schaljo, et al.
Cell Host & Microbe|October 28, 2020
Distinct Polysaccharide Utilization Determines Interspecies Competition between Intestinal Prevotella sppEric J C Gálvez, Aida Iljazovic, Lena Amend, et al.
Pageof 9